No evidence seen for link between childhood stimulant treatment and substance use during adolescence and young adulthood
Review shows positive effects on cessation of substance use, aerobic capacity, depressive symptoms
Median monthly retention rate was 22.2 percent during January 2016 through April 2022
Authors say this may reflect peer influence on substance use, as decreases were not seen for older adults
Maternal, neonatal outcomes similar to buprenorphine monotherapy
For men aged 65 to 74 and 75 years or older, drug overdose death rates were higher for non-Hispanic Black men
New scientific statement on managing infective endocarditis in people who inject drugs emphasizes importance of addiction-trained clinicians
Increase in methadone-involved deaths in March 2020 not thought to be tied to expanded opioid treatment program take-home policies
Insufficient sleep duration, inconsistent timing of sleep tied to mental health symptoms and substance use
One-third of teens show early depression response with substance use treatment alone